Viability and apoptosis in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20217)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction | Replicate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PLX-4720 | SKMEL28 | 3.1600 | uM | 72 | hr | 547 | 61 | 0.3646 | 0.3891 | 0.1115 | 0.1047 | 2 |
Vemurafenib | SKMEL28 | 3.1600 | uM | 72 | hr | 630 | 95 | 0.4013 | 0.3895 | 0.1508 | 0.1466 | 4 |
Vemurafenib | SKMEL28 | 3.1600 | uM | 72 | hr | 651 | 80 | 0.4283 | 0.3895 | 0.1229 | 0.1466 | 3 |
Vemurafenib | SKMEL28 | 3.1600 | uM | 72 | hr | 562 | 87 | 0.3563 | 0.3895 | 0.1548 | 0.1466 | 2 |
Vemurafenib | SKMEL28 | 3.1600 | uM | 72 | hr | 589 | 93 | 0.3721 | 0.3895 | 0.1579 | 0.1466 | 1 |
AZ-628 | COLO 858 | 0.3160 | uM | 72 | hr | 1299 | 283 | 0.3690 | 0.3922 | 0.2179 | 0.2252 | 2 |
AZ-628 | COLO 858 | 0.3160 | uM | 72 | hr | 1238 | 278 | 0.3487 | 0.3922 | 0.2246 | 0.2252 | 1 |
AZ-628 | COLO 858 | 0.3160 | uM | 72 | hr | 1466 | 303 | 0.4224 | 0.3922 | 0.2067 | 0.2252 | 3 |
AZ-628 | COLO 858 | 0.3160 | uM | 72 | hr | 1577 | 397 | 0.4286 | 0.3922 | 0.2517 | 0.2252 | 4 |
Vemurafenib | COLO 858 | 1.0000 | uM | 72 | hr | 1660 | 441 | 0.4428 | 0.3928 | 0.2657 | 0.2502 | 3 |
Vemurafenib | COLO 858 | 1.0000 | uM | 72 | hr | 1433 | 333 | 0.3996 | 0.3928 | 0.2324 | 0.2502 | 4 |
Vemurafenib | COLO 858 | 1.0000 | uM | 72 | hr | 1495 | 369 | 0.4090 | 0.3928 | 0.2468 | 0.2502 | 1 |
Vemurafenib | COLO 858 | 1.0000 | uM | 72 | hr | 1184 | 303 | 0.3200 | 0.3928 | 0.2559 | 0.2502 | 2 |
SB590885 | C32 | 3.1600 | uM | 48 | hr | 1909 | 958 | 0.4627 | 0.3996 | 0.5018 | 0.5238 | 4 |
SB590885 | C32 | 3.1600 | uM | 48 | hr | 1850 | 944 | 0.4408 | 0.3996 | 0.5103 | 0.5238 | 3 |
SB590885 | C32 | 3.1600 | uM | 48 | hr | 1545 | 846 | 0.3401 | 0.3996 | 0.5476 | 0.5238 | 2 |
SB590885 | C32 | 3.1600 | uM | 48 | hr | 1569 | 840 | 0.3547 | 0.3996 | 0.5354 | 0.5238 | 1 |
PLX-4720 | COLO 858 | 1.0000 | uM | 48 | hr | 2238 | 304 | 0.4419 | 0.4070 | 0.1358 | 0.1839 | 2 |
PLX-4720 | COLO 858 | 1.0000 | uM | 48 | hr | 2029 | 413 | 0.3692 | 0.4070 | 0.2036 | 0.1839 | 3 |
PLX-4720 | COLO 858 | 1.0000 | uM | 48 | hr | 2445 | 635 | 0.4136 | 0.4070 | 0.2597 | 0.1839 | 4 |
PLX-4720 | COLO 858 | 1.0000 | uM | 48 | hr | 2045 | 279 | 0.4035 | 0.4070 | 0.1364 | 0.1839 | 1 |
Selumetinib | WM-115 | 1.0000 | uM | 72 | hr | 1778 | 642 | 0.3747 | 0.4086 | 0.3611 | 0.3021 | 1 |
Selumetinib | WM-115 | 1.0000 | uM | 72 | hr | 1782 | 557 | 0.4041 | 0.4086 | 0.3126 | 0.3021 | 2 |
Selumetinib | WM-115 | 1.0000 | uM | 72 | hr | 1691 | 446 | 0.4107 | 0.4086 | 0.2638 | 0.3021 | 3 |
Selumetinib | WM-115 | 1.0000 | uM | 72 | hr | 1850 | 501 | 0.4450 | 0.4086 | 0.2708 | 0.3021 | 4 |